Published in Nephrol Dial Transplant on November 25, 2011
Endothelial dysfunction exacerbates renal interstitial fibrosis through enhancing fibroblast Smad3 linker phosphorylation in the mouse obstructed kidney. PLoS One (2013) 0.80
TJ0711, a novel vasodilatory β-blocker, protects SHR rats against hypertension induced renal injury. Am J Transl Res (2013) 0.79
Enhancing eNOS activity with simultaneous inhibition of IKKβ restores vascular function in Ins2(Akita+/-) type-1 diabetic mice. Lab Invest (2015) 0.79
Novel gene delivery systems. Int J Pharm Investig (2013) 0.77
Endothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria. PLoS One (2016) 0.76
Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury. J Diabetes Res (2017) 0.75
Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature (2012) 4.26
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2005) 2.13
Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats. J Hypertens (2005) 2.04
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Can J Cardiol (2005) 2.03
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol (2012) 1.86
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol (2013) 1.85
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2009) 1.64
The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy. Can J Cardiol (2002) 1.49
The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. Can J Cardiol (2004) 1.46
Endothelin is a dose-dependent trophic factor and a mitogen in small arteries in vivo. Cardiovasc Res (2006) 1.45
Role of oxidative stress in erythropoietin-induced hypertension in uremic rats. Am J Hypertens (2009) 1.44
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2010) 1.44
The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol (2011) 1.38
Forearm reactive hyperemia and mortality in end-stage renal disease. Kidney Int (2004) 1.30
The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2004) 1.20
Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Am J Kidney Dis (2009) 1.09
Endothelial function and chronic exposure to air pollution in normal male subjects. Hypertension (2007) 1.08
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2010) 1.07
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2008) 1.05
2009 Canadian Hypertension Education Program recommendations: the scientific summary--an annual update. Can J Cardiol (2009) 1.03
Local shear stress and brachial artery functions in end-stage renal disease. J Am Soc Nephrol (2007) 1.02
The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification. Can J Cardiol (2002) 1.02
Impact of age on glomerular filtration estimates. Nephrol Dial Transplant (2008) 1.01
2010 Canadian Hypertension Education Program (CHEP) recommendations: the scientific summary - an update of the 2010 theme and the science behind new CHEP recommendations. Can J Cardiol (2010) 0.99
Endothelial and vascular dysfunctions and insulin resistance in rats fed a high-fat, high-sucrose diet. Am J Physiol Heart Circ Physiol (2008) 0.98
Determinants of progression of aortic stiffness in hemodialysis patients: a prospective longitudinal study. Hypertension (2013) 0.94
RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes. Arterioscler Thromb Vasc Biol (2011) 0.93
Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. J Clin Invest (2005) 0.92
Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure. Am J Nephrol (2012) 0.91
Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension. J Hypertens (2002) 0.90
Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients. Am J Kidney Dis (2005) 0.90
Induction of insulin resistance by high-sucrose feeding does not raise mean arterial blood pressure but impairs haemodynamic responses to insulin in rats. Br J Pharmacol (2002) 0.88
Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat. Eur J Pharmacol (2009) 0.87
Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease. Clin Exp Hypertens (2013) 0.86
Impact of dialysate calcium concentration on the progression of aortic stiffness in patients on haemodialysis. Nephrol Dial Transplant (2011) 0.84
Estimation of heparin leak into the systemic circulation after central venous catheter heparin lock. Nephrol Dial Transplant (2005) 0.83
Age-related and blood pressure-independent reduction in aortic stiffness after kidney transplantation. J Hypertens (2011) 0.83
Tumor necrosis factor inhibitors as novel therapeutic tools for vascular remodeling diseases. Am J Physiol Heart Circ Physiol (2010) 0.83
A patient with a juxtaglomerular cell tumor with histological vascular invasion. Nat Clin Pract Nephrol (2008) 0.83
Endothelin-1 in chronic renal failure and hypertension. Can J Physiol Pharmacol (2003) 0.82
The impact of arteriovenous fistulas on aortic stiffness in patients with chronic kidney disease. Nephrol Dial Transplant (2009) 0.81
Incidence and severity of early electrolyte abnormalities following autologous haematopoietic stem cell transplantation. Nephrol Dial Transplant (2007) 0.81
Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats. Prostaglandins Leukot Essent Fatty Acids (2004) 0.80
Dual-kidney transplants as an alternative for very marginal donors: long-term follow-up in 63 patients. Transplantation (2010) 0.80
Effects of acute variation of dialysate calcium concentrations on arterial stiffness and aortic pressure waveform. Nephrol Dial Transplant (2009) 0.80
Effects of high-sucrose feeding on insulin resistance and hemodynamic responses to insulin in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol (2006) 0.79
Atherosclerotic renovascular disease. Can J Cardiol (2006) 0.79
Effect of erythropoietin on blood pressure and on the vascular endothelial ET-1/ETB receptor system. Am J Hypertens (2008) 0.79
Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy. Transplantation (2015) 0.78
Increased ET-1 and reduced ET(B) receptor expression in uremic hypertensive rats. Clin Exp Hypertens (2010) 0.78
Arterial stiffness and dialysis calcium concentration. Int J Nephrol (2011) 0.78
Functional tests for primary aldosteronism: value of captopril suppression. Curr Hypertens Rep (2002) 0.78
Endothelin-1 levels and cardiovascular risk factors in renal transplant patients. Clin Biochem (2004) 0.77
Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats. Can J Physiol Pharmacol (2005) 0.77
Impact of donor age on long-term outcomes after delayed graft function: 10-year follow-up. Transpl Int (2012) 0.77
Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. Am J Hypertens (2006) 0.77
Morning plasma aldosterone predicts the subtype of primary aldosteronism independent of sodium intake. Clin Exp Hypertens (2007) 0.77
Heterogeneity in the acute control of vascular protein synthesis in vivo. J Vasc Res (2003) 0.77
Advanced glycation end products, aortic stiffness, and wave reflection in peritoneal dialysis as compared to hemodialysis. Int Urol Nephrol (2013) 0.77
Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism. Int J Nephrol Renovasc Dis (2011) 0.77
Insights from ambulatory blood pressure monitoring: diagnosis of hypertension and diurnal blood pressure in renal transplant recipients. Transplantation (2004) 0.77
Effects of tempol on endothelial and vascular dysfunctions and insulin resistance induced by a high-fat high-sucrose diet in the rat. Can J Physiol Pharmacol (2013) 0.76
Relationship between eicosanoids and endothelin-1 in the pathogenesis of erythropoietin-induced hypertension in uremic rats. J Cardiovasc Pharmacol (2003) 0.76
Hypertension in dialysis and kidney transplant patients. Can J Cardiol (2009) 0.75
Heart rate dependent and independent effects of beta-blockers on central hemodynamic parameters: a propensity score analysis. J Hypertens (2016) 0.75
Systolic blood pressure diurnal variation is not a predictor of renal target organ damage in kidney transplant recipients. Am J Transplant (2004) 0.75
Greenhouse Gas Emissions after Application of Landfilled Paper Mill Sludge for Land Reclamation of a Nonacidic Mine Tailings Site. J Environ Qual (2017) 0.75
Green dialysate: asymptomatic perforated cholecystitis without peritonitis. Nephrol Dial Transplant (2006) 0.75
Acute effects of cinacalcet on arterial stiffness and ventricular function in hemodialysis patients: A randomized double-blinded crossover study. Medicine (Baltimore) (2017) 0.75
Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease. J Hypertens (2017) 0.75
In vivo quantification of central venous catheter leak. Nephrol Dial Transplant (2005) 0.75
Effects of TGF-beta1 on endothelial factors. Arch Physiol Biochem (2010) 0.75
Uric acid association with pulsatile and steady components of central and peripheral blood pressures. J Hypertens (2017) 0.75
Uncovering the Minor Contribution of Land-Cover Change in Upland Forests to the Net Carbon Footprint of a Boreal Hydroelectric Reservoir. J Environ Qual (2015) 0.75